 |
|
| |
|
| Abstract Submission is now closed. The Symposium Manager will accept changes to the abstract submitted by email till 6 October 2008. Notification of Acceptance for abstract submitted has been sent out via email on 9 October 2008. |
| |
|
| Abstracts Submission Closes: |
30 September 2008 |
| Review Results: |
15 October 2008 |
| *Please note that each Presenter is allowed to submit a maximum number of 5 abstracts. |
|
|
| |
|
|
| |
|
| The 1st Asia-Pacific Heart Rhythm Society Scientific Session (APHRS 2008) offers 9 categories and 46 subcategories. Each category offers numerous subcategories to which an author may submit an abstract. The subcategory choice will allow the appropriate APHRS 2008 Review Committee to review this abstract.
While the categories may look familiar, there have been some changes to the subcategories. If you are a returning abstract submitter, please read the list below carefully before choosing the subcategory. |
| |
| Subcategory Descriptions |
Most subcategories are self-descriptive, however below are a few that require more explanation:
Cases
An abstract subcategory for physicians covering case-based abstracts. Submit interesting cases that feature unique physiology; challenging diagnoses; new strategies for patient management; unusual complications or adverse affects, challenging interpretations of ICD/pacemaker function, or innovative technologies that facilitate procedures or patient management. If you are an Allied Professional who wishes to submit a case-based abstract, please see the paragraph below.
Allied Professional: Cases
A subcategory for all case-based abstracts submitted by allied professionals.
Allied Professional: Research Studies
A subcategory for all non-case-based abstract submitted by allied professionals. |
| |
| Abstract categories and subcategories are as follows: |
| • |
Allied Professionals: Research Studies |
| • |
Allied Professionals: Case-Based |
| • |
Basic/Translational Science: Ion Channels & Transporters: Structure, Function & Regulation |
| • |
Basic/Translational Science: Structure: Anatomy & Pathology |
| • |
Basic/Translational Science: Genomics |
| • |
Basic/Translational Science: Cell Physiology, Pharmacology, & Signaling |
| • |
Basic/Translational Science: Computer Modeling/Simulation |
| • |
Basic/Translational Science: Intact Heart Electrophysiology (includes Pharmacology & Optical Mapping) |
| • |
Basic/Translational Science: Whole Animal Electrophysiology & Pharmacology (includes Neurohumoral Modulation) |
| • |
Catheter Ablation: Accessory Pathways, Atrioventricular Nodal Reentrant Tachycardia |
| • |
Catheter Ablation: Atrial Flutter, Atrial Tachycardia |
| • |
Catheter Ablation: Atrial Fibrillation |
| • |
Catheter Ablation: Ventricular Tachyarrhythmias |
| • |
Catheter Ablation: Clinical Issues (Sedation, Radiology, etc.) |
| • |
Catheter Ablation: Experimental Methods |
| • |
Catheter Ablation: Cardiac Mapping |
| • |
Clinical EP/Pharmacology: Clinical Trials, Follow Up and Outcome |
| • |
Clinical EP/Pharmacology: Electrophysiologic Evaluation of Atrial Fibrillation |
| • |
Clinical EP/Pharmacology: SVT/Electrophysiologic Evaluation of SVT |
| • |
Clinical EP/Pharmacology: Genomics |
| • |
Clinical EP/Pharmacology: VT/Electrophysiologic Evaluation of VT |
| • |
Clinical EP/Pharmacology: Electrophysiologic Evaluation of Bradyarrhythmias |
|
|
| • |
Devices - Bradycardia: Indications |
| • |
Devices - Bradycardia: Device Technology |
| • |
Devices - Bradycardia: Clinical Trials, Follow Up & Outcomes |
| • |
Devices - CRT: Indications |
| • |
Devices - CRT: Device Technology |
| • |
Devices - CRT: Clinical Trials, Follow Up & Outcomes |
| • |
Devices - Implantable: Hemodynamics, Monitors, Sensors, Physiologic/Pharmacologic Interactions |
| • |
Devices - Implantable: Implantation & Extraction Techniques |
| • |
Devices - Implantable: Lead Technology |
| • |
Devices - Implantable: Therapy for Atrial Fibrillation: Diagnostics, Prevention & Treatment |
| • |
Devices - Tachycardia: Indications |
| • |
Devices - Tachycardia: Device Technology |
| • |
Devices - Tachycardia: Clinical Trials, Follow Up & Outcomes |
| • |
Devices - Tachycardia: External Defibrillators |
| • |
Noninvasive Evaluation: Signal Average ECG/T-Wave Alternans |
| • |
Noninvasive Evaluation: Ambulatory ECG/Heart Rate Variability/QT Interval |
| • |
Noninvasive Evaluation: Tilt Table Testing/Syncope |
| • |
Noninvasive Evaluation: Electrocardiography |
| • |
Noninvasive Evaluation: Other Noninvasive Techniques |
| • |
Pediatric Cardiology |
| • |
Adult Congenital Heart Disease |
| • |
Regulatory & Health Policy |
| • |
Training & Education |
| • |
Cases |
|
|
| |
| Brief Submission Guideline |
| Abstract Data |
| • |
Multiple abstracts appearing to be redundant versions of a single study will be rejected. |
| • |
Abstracts are not eligible for consideration if published prior to the 29th Annual Scientific Sessions. No abstract may be presented at the Annual Scientific Sessions if it is substantially similar to material presented or to be presented at a major meeting held prior to the Annual Scientific Sessions. |
| • |
Individuals who have submitted abstracts to other major meetings and are awaiting notification of acceptance may also submit abstracts to the Heart Rhythm Society for consideration for the 29th Annual Scientific Sessions; however, upon acceptance from another organization, it is the responsibility of the author to notify the Heart Rhythm Society office by Wednesday, 15 October 2008 to withdraw the abstract. |
| • |
The Committee endorses the position of the American Association for the Advancement of Science in requiring assurances of the responsible use of animals in research (AAAS Resolution: Use of Animals in Research, Testing, and Education). All submissions must be in compliance with these guidelines. |
| • |
Any human experimentation must conform to the principles of the Declaration of Helsinki of the World Medical Association (WMA Declaration of Helsinki). |
| • |
The Presenting Author must ensure that all co-authors are familiar with the data, agree with the stated results, and have agreed to be included as authors. |
| • |
Upon the abstract’s acceptance, authors will be asked to read and comply with the Heart Rhythm Society’s Release and Authorization for Audio Tapes/CD-ROMs, Webcasts, and Enduring Products. |
|
| |
| Abstract Format |
The total number of words allowed for each submission is 250, inclusive of the word count for the Abstract Title. The character count does not include spaces.
| The abstract must include the following: |
| • |
Abstract Title |
| • |
Aim / Objective |
| • |
Method |
| • |
Abstract Content |
| • |
Abstract Conclusion |
|
| |
| Abstract Resubmission/Amendment |
| Resubmission of an abstract that is corrected or changed is not possible after the abstract deadline date. |
| |
| Disclosure of Relationship and Conflict of Interest |
| The Presenting Author must disclose all of her/his financial relationships upon an abstract’s acceptance. |
| |
| Abstract Withdrawal |
| Requests for withdrawal of an abstract must be received in writing by Wednesday, 15 October 2008. |
